Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 37.15 INR
Change Today -0.80 / -2.11%
Volume 38.7K
PRNX On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:28 AM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

parnax lab ltd (PRNX) Snapshot

Open
37.50
Previous Close
37.95
Day High
39.40
Day Low
35.60
52 Week High
07/18/14 - 57.65
52 Week Low
05/28/15 - 21.05
Market Cap
316.0M
Average Volume 10 Days
45.6K
EPS TTM
4.99
Shares Outstanding
8.5M
EX-Date
--
P/E TM
7.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for PARNAX LAB LTD (PRNX)

Related News

No related news articles were found.

parnax lab ltd (PRNX) Related Businessweek News

No Related Businessweek News Found

parnax lab ltd (PRNX) Details

Parnax Lab Limited manufactures and sells pharmaceutical formulations in India. It offers liquid orals, ointments, and external powders. The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. Parnax Lab Limited was incorporated in 1982 and is based in Mumbai, India.

Founded in 1982

parnax lab ltd (PRNX) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

parnax lab ltd (PRNX) Key Developments

Parnax Lab Limited Announces Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Parnax Lab Limited announced audited standalone and consolidated earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 38.778 million compared to INR 45.544 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 2.257 million compared to INR 1.75 million for the same period a year ago. Loss from ordinary activities before tax was INR 1.462 million compared to loss from ordinary activities before tax of INR 5.3 million for the same period a year ago. Net loss was INR 1.462 million or INR 0.17 per basic and diluted share before and after extraordinary items compared to net loss of INR 5.30 million or INR 0.62 per basic and diluted share before and after extraordinary items for the same period a year ago. For the year, on standalone basis, the company reported net sales/income from operations (net of excise duty) of INR 158.555 million compared to INR 179.415 million for the same period a year ago. Loss from operations before other income, finance costs and exceptional items was INR 3.397 million compared to profit from operations before other income, finance costs and exceptional items of INR 1.574 million for the same period a year ago. Loss from ordinary activities before tax was INR 17.541 million compared to INR 14.663 million for the same period a year ago. Net loss was INR 11.979 million or INR 1.41 per basic and diluted share before and after extraordinary items compared to net loss of INR 12.139 million or INR 1.43 per basic and diluted share before and after extraordinary items for the same period a year ago. For the quarter, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 259.815 million compared to INR 216.669 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 22.482 million compared to INR 12.512 million for the same period a year ago. Profit from ordinary activities before tax was INR 10.970 million compared to loss from ordinary activities before tax of INR 0.736 million for the same period a year ago. Net profit after taxes, minority interest and share of associates was INR 10.980 million or INR 1.29 per basic and diluted share before and after extraordinary items compared to net loss after taxes, minority interest and share of associates of INR 0.745 million or INR 0.09 per basic and diluted share before and after extraordinary items for the same period a year ago. For the year, on consolidated basis, the company reported net sales/income from operations (net of excise duty) of INR 1,027.463 million compared to INR 685.735 million for the same period a year ago. Profit from operations before other income, finance costs and exceptional items was INR 98.391 million compared to INR 72.85 million for the same period a year ago. Profit from ordinary activities before tax was INR 54.414 million compared to INR 34.08 million for the same period a year ago. Net profit after taxes, minority interest and share of associates was INR 42.462 million or INR 4.99 per basic and diluted share before and after extraordinary items compared to net profit after taxes, minority interest and share of associates of INR 24.86 million or INR 2.92 per basic and diluted share before and after extraordinary items for the same period a year ago.

Parnax Lab Limited, Board Meeting, May 29, 2015

Parnax Lab Limited, Board Meeting, May 29, 2015. Agenda: To consider the audited results.

Parnax Lab Ltd Approves Executive Appointments

Parnax Lab Ltd. announced that the Board of Directors of the company at its meeting held on March 31, 2015, approved the appointment of Mrs. Mihir Shah as women director of the company and Mr. T. V. Anantharaman as an Independent director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRNX:IN 37.15 INR -0.80

PRNX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRNX.
View Industry Companies
 

Industry Analysis

PRNX

Industry Average

Valuation PRNX Industry Range
Price/Earnings 6.8x
Price/Sales 0.3x
Price/Book 1.2x
Price/Cash Flow 4.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PARNAX LAB LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.